Results: Baseline characteristics for 150 participants were as follows, age 56☙.5 years, 78.7% male, 25% diabetics, 82% hypertensives, and 36% had hypercholesterolemia.
Clinical secondary endpoints included the individual components of the primary endpoint, death, nonfatal recurrent MI, and repeat target vessel revascularization. The primary endpoint was a composite of MACE (death, repeat target-vessel revascularization, and non-fatal recurrent MI) at the end of 36 months of follow up. TIMI risk score was calculated for each patient at admission. Methods: This was a retrospective observational cohort study of consecutive NSTE-ACS patients (n=150) treated by percutaneous coronary intervention between January 2017 to June 2017 in a tertiary care center. This study aims at assessing the long term prognostic significance of TIMI risk score, 36 months after revascularization in NSTE-ACS. However, few studies have evaluated the long term prognostic significance of TIMI risk score after revascularization. Primarily thrombolysis in myocardial infarction (TIMI) risk score was developed to guide therapy and assess the short term (14 days) prognosis of these patients. Long term prognosis, NSTE-ACS, Percutaneous coronary intervention, Risk stratification, TIMI risk score Abstractīackground: Non-ST elevation acute coronary syndrome (NSTE-ACS) patients are complex and varied population. SN Medical College, Jodhpur, Rajasthan, India
0 kommentar(er)
